Fermented Soy Extract Improves Bone Microarchitecture and Neuroendocrine Balance in Ovariectomized Mice

Postmenopausal osteoporosis is a significant health concern characterized by accelerated bone loss due to estrogen deficiency, leading to increased fracture risk. Current therapies often have side effects, driving interest in natural interventions. Beyond bone health, menopause also impacts neuroendocrine regulation, affecting mood and cognitive function. This study investigates fermented soy extract (FSE) as a potential multi-target therapeutic, leveraging its known phytoestrogenic properties to address both bone metabolism and neuroendocrine imbalances associated with menopause.

Researchers evaluated the effects of fermented soy extract (FSE) in an ovariectomized (OVX) mouse model, which mimics postmenopausal conditions. Mice were administered FSE, though specific doses and routes were not detailed in the abstract. The study assessed bone microarchitecture using unspecified methods and analyzed key markers of bone turnover, including CTX-1, RANKL, and OPG expression. Additionally, the team investigated estrogen receptor-related activity and the expression of genes involved in bone metabolism. Neuroendocrine parameters, specifically estradiol, serotonin, and norepinephrine levels, were also measured.

Fermented soy extract (FSE) administration significantly improved bone microarchitecture in ovariectomized mice, indicating a protective effect against bone loss. The study observed a modulation of critical bone turnover markers: FSE reduced levels of CTX-1 and RANKL, while simultaneously increasing OPG expression. These changes collectively suggest a suppression of osteoclastogenesis, the process of bone resorption. Furthermore, FSE enhanced estrogen receptor-related activity and upregulated genes crucial for maintaining healthy bone metabolism. Beyond bone, FSE demonstrated a beneficial role in neuroendocrine regulation. > FSE notably increased circulating levels of estradiol, serotonin, and norepinephrine, suggesting a positive impact on hormonal balance and neurotransmitter systems often disrupted during menopause. These findings collectively highlight FSE's potential to address multiple facets of postmenopausal decline.